Literature DB >> 2408644

Atracurium: clinical strategies for preventing histamine release and attenuating the haemodynamic response.

R P Scott, J J Savarese, S J Basta, N Sunder, H H Ali, M Gargarian, M Gionfriddo, A G Batson.   

Abstract

This study was designed to determine the effects of a rapid bolus dose of atracurium 0.6 mg kg-1 on arterial pressure, heart rate and plasma histamine concentration (n = 9), and to compare these values with those obtained by (a) giving the same dose of atracurium slowly (over 75 s) (n = 9), or (b) pre-treating with H1- and H2- antagonists (n = 9). The rapid (5-s) bolus dose of atracurium i.v. resulted in a significant increase in plasma histamine concentration (P less than 0.05) and was associated with a decrease in mean arterial pressure and an increase in heart rate. Administering the same dose of atracurium slowly (over 75 s) prevented the increase in plasma histamine concentration, and abolished the subsequent haemodynamic response. Pretreatment with cimetidine 4 mg kg-1 i.v. and chlorpheniramine 0.1 mg kg-1 i.v. abolished the haemodynamic response despite a moderate increase in histamine concentration (0.1 greater than P greater than 0.05).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2408644     DOI: 10.1093/bja/57.6.550

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  10 in total

1.  Anaphylactoid reactions following propofol-atracurium sequence.

Authors:  C H McLeskey
Journal:  Can J Anaesth       Date:  1990-11       Impact factor: 5.063

2.  Wheal and flare responses to muscle relaxants in humans.

Authors:  J H Levy; D Adelson; B Walker
Journal:  Agents Actions       Date:  1991-11

Review 3.  Anaesthesia in the elderly. Special considerations.

Authors:  A G Jones; J M Hunter
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

4.  Prophylactic administration of histamine1 and histamine2 receptor blockers in the prevention of protamine-related haemodynamic effects.

Authors:  J Kambam; R Meszaros; W Merrill; J Stewart; B E Smith; H Bender
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

Review 5.  Adverse effects of nondepolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  M Abel; W J Book; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

Review 6.  Adverse effects of neuromuscular blockers and their antagonists.

Authors:  M Naguib; M M Magboul
Journal:  Drug Saf       Date:  1998-02       Impact factor: 5.606

Review 7.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

8.  Interaction between succinylcholine and cimetidine in rats.

Authors:  Y Mishra; I Ramzan
Journal:  Can J Anaesth       Date:  1992-04       Impact factor: 5.063

9.  Chirality and anaesthetic drugs: A review and an update.

Authors:  Sukanya Mitra; Puneet Chopra
Journal:  Indian J Anaesth       Date:  2011-11

10.  The Incidence of hypotension with continuous infusion atracurium compared to cisatracurium in the Intensive Care Unit.

Authors:  Luke A VanderWeide; Mahmoud Abdel-Rasoul; Anthony Thomas Gerlach
Journal:  Int J Crit Illn Inj Sci       Date:  2017 Apr-Jun
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.